2009 Department of Head and Neck Formal 1 n/a Otolaryngology Cancer Preclinical Presentation Head and Neck Models SPORE meeting 2010 Eye and Ear Targeting the Formal 1 n/a Foundation epidermal Presentation Scientific Advisory growth factor Meeting receptor with antisense guanidinium, peptide nucleic acids 2011 Fourth Cross-talk Formal 1 n/a International between head Presentation Symposium on and neck cancer Translational cells and stromal Cancer Research: fibroblasts Recent facilitates tumor developments in progression cancer prevention 2012 University of Texas EGFR antisense Formal 1 n/a gene therapy: Presentation Progress toward systemic delivery 2012 Department of EGFR antisense Formal 1 n/a Pharmacology and gene therapy: Presentation Chemical Biology Progress toward Seminar Series, systemic delivery University of Pittsburgh 2012 Department of Deviant Formal 1 n/a Otolaryngology, of Presentation University of Kansas head and neck Medical Center cancer progression 2013 Department of Deviant Formal 1 n/a Otolaryngology, of Presentation University of head and neck Rochester Medical cancer Center progression 2013 Department of Demystifying Grand Rounds 1 hour n/a Otolaryngology, Translational University of Kansas Research Medical Center 2013 Department of Antisense Gene Formal 1 hour n/a Pharmacology, Therapy Using Presentation Toxicology, Guanidinium University of Kansas Peptide Nucleic Medical Center Acid Oligomers 2013 Cancer Biology The role of Formal 1 hour n/a Monthly Meeting, associated Presentation University of Kansas fibroblasts in head and neck cancer progression
2009 Department of Otolaryngology Head and Neck SPORE meeting Head and Neck Cancer Preclinical Models Formal Presentation 1 n/a 2010 Eye and Ear Foundation Scientific Advisory Meeting Targeting the epidermal growth factor receptor with antisense guanidinium, peptide nucleic acids Formal Presentation 1 n/a 2011 Fourth International Symposium on Translational Cancer Research: Recent developments in cancer prevention Cross-talk between head and neck cancer cells and stromal fibroblasts facilitates tumor progression Formal Presentation 1 n/a 2012 University of Texas EGFR antisense gene therapy: Progress toward systemic delivery Formal Presentation 1 n/a 2012 Department of Pharmacology and Chemical Biology Seminar Series, University of Pittsburgh EGFR antisense gene therapy: Progress toward systemic delivery Formal Presentation 1 n/a 2012 Department of Otolaryngology, University of Kansas Medical Center Deviant of head and neck cancer progression Formal Presentation 1 n/a 2013 Department of Otolaryngology, University of Rochester Medical Center Deviant of head and neck cancer progression Formal Presentation 1 n/a 2013 Department of Otolaryngology, University of Kansas Medical Center Demystifying Translational Research Grand Rounds 1 hour n/a 2013 Department of Pharmacology, Toxicology, University of Kansas Medical Center Antisense Gene Therapy Using Guanidinium Peptide Nucleic Acid Oligomers Formal Presentation 1 hour n/a 2013 Cancer Biology Monthly Meeting, University of Kansas The role of fibroblasts in head and neck cancer progression Formal Presentation 1 hour n/a associated
Thomas%20SOM%20CV%20050217.docx